Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Frontier Medicines Corporation
Beijing Biotech
Filamon LTD
Bristol-Myers Squibb
Revolution Medicines, Inc.
University of Virginia
AstraZeneca
NeoImmuneTech
Verastem, Inc.
EMD Serono
Anova Innovation Limited
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
Lokon Pharma AB
Dana-Farber Cancer Institute
Intima Bioscience, Inc.
Amplia Therapeutics Limited
A2 Biotherapeutics Inc.
AstraZeneca
M.D. Anderson Cancer Center
Arvinas Inc.
Essen Biotech